Physician

Marvi Bikak, M.D

According to 2025 Medicare claims, Marvi Bikak, M.D (NPI: 1548600380) practices critical care (intensivists) in the Michigan City-La Porte, IN market, with the plurality of this provider's patient population coming from La Porte, IN. This provider's primary affiliated billing organization is LA PORTE CLINIC COMPANY LLC (NPI: 1568829224; TIN: 810745237) and primary practice location at 46350-3115. Bikak is affiliated with the CHSPSC ACO 21, LLC (ACO ID: A3698), Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), and Sound Physicians Long Term Care Managment II (ACO ID: A5538), participating under the MSSP model.

Bikak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 613 traditional Medicare patients, billed 2,364 HCPCS/CPT codes, and received $146,706 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,396 prescription claims across 387 beneficiaries totaling $1,198,424 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,184 claims. Open Payments data shows 142 records totaling $17,460. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $149,752 and ending at $146,706. Concurrently, Part D prescription costs have risen steadily, from $2,592 to $1,198,424. For DME billing, reported payments moved sharply higher in recent years, from $1,970 to $128,349.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	259	1,330	$149,752
2021	572	3,463	$357,704
2022	483	2,128	$206,374
2023	485	1,653	$108,291
2024	613	2,364	$146,706

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	24	57	$2,592
2016	20	69	$9,202
2017	22	92	$30,037
2018	28	173	$25,868
2019	21	109	$12,576
2020	55	131	$21,366
2021	124	481	$125,333
2022	154	789	$374,906
2023	209	861	$391,709
2024	387	2,396	$1,198,424

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	185	$19,442
2022	90	491	$89,179
2023	198	657	$124,311
2024	385	1,184	$126,502

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	174	174	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	251	545	$86
94727	Test to determine lung volumes using gas dilution or washout	163	163	$8
94060	Test to measure expiratory airflow and volume changes before and after medication administration	167	168	$7
94729	Test to examine how well the lungs exchange gases	165	165	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	502	17,790	$374,948
Fasenra Pen	Benralizumab	40	2,044	$238,962
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	163	5,068	$105,416
Dupixent Pen	Dupilumab	26	714	$100,465
Nucala	Mepolizumab	25	700	$92,520

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	15	95	$81,753
E0601	Continuous positive airway pressure (cpap) device	Y	29	210	$7,010
A7030	Full face mask used with positive airway pressure device, each	N	35	69	$6,049
A7031	Face mask interface, replacement for full face mask, each	N	32	68	$4,902
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	13	45	$3,808

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	142	$17,460	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Marvi Bikak, M.D?

Tedicare shows public-source Medicare data for Marvi Bikak, M.D (NPI 1548600380), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Marvi Bikak, M.D have ACO affiliation data?

Marvi Bikak, M.D is shown with ACO affiliation data for CHSPSC ACO 21, LLC (MSSP, ACO ID A3698), Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502), and Sound Physicians Long Term Care Managment II (MSSP, ACO ID A5538).

What billing organization is linked to Marvi Bikak, M.D?

Marvi Bikak, M.D is linked to LA PORTE CLINIC COMPANY LLC (billing NPI 1568829224) in the available physician profile data.

Does Marvi Bikak, M.D have Open Payments data?

Marvi Bikak, M.D has 142 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.